Telemedicine platform Hims & Hers Health's shares plummeted 10%. Earlier, Visa issued a warning that the company received too many customer complaints in its weight loss subscription business. Documents reviewed by Bloomberg show that due to a surge in customer credit card disputes in July, the telemedicine company has been included in Visa's billing agency monitoring program. The stock has accumulated a decline of about 4.3% since this year. According to data compiled by Bloomberg, HIMS received 5 buy ratings, 12 hold ratings, and 0 sell ratings; the average target price was $31.77.

Zhitongcaijing · 3d ago
Telemedicine platform Hims & Hers Health's shares once plummeted 10%. Earlier, Visa issued a warning that the company received too many customer complaints in its weight loss subscription business. Documents reviewed by Bloomberg show that due to a surge in customer credit card disputes in July, the telemedicine company has been included in Visa's billing agency monitoring program. The stock has accumulated a decline of about 4.3% since this year. According to data compiled by Bloomberg, HIMS received 5 buy ratings, 12 hold ratings, and 0 sell ratings; the average target price was $31.77.